Synthetic Biologics (SYN) Reports Eradication of Gut Methane Improves Insulin Sensitivity
Tweet Send to a Friend
Synthetic Biologics, Inc. (NYSE: SYN) today announced that researchers at Cedars-Sinai Medical Center (Cedars-Sinai) found that eradication of breath methane ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
